Back to search
FDAFDA · Food and drugs·Recall number Z-2966-2026

Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen REF(s):L2kSY2/10489085; L2KSY6/10488319 IVD, RxOnly

Published August 26, 2026 · Recall initiated: July 13, 2026

Summary

FDA records medical device Class II recall Z-2966-2026, published August 26, 2026 and initiated July 13, 2026. Recalling firm: Siemens Healthcare Diagnostics Products Ltd.; Status: Ongoing; Reported quantity: 478 units; Lot: Lot Code: D387/UDI(s):L2KSY2-00630414999791; L2KSY6 - 00630414999807. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics Products Ltd.
Distributor
Worldwide - US Nationwide distribution in the states of FL, NJ, NY and the countries of Austria, Azerbaijan, Belgium, Brazil, Chile, Colombia, Cura-ao, St.¿Eus Cyprus, France, Germany, Italy, Kazakhstan, Latvia, Lithuania, Netherlands, Romania, Russian®Fed., Saudi®Arabia, Slovakia, Slovenia, South®Africa, Spain, U.A.E., Ukraine, United®Kingdom, Uzbekistan.¿¿¿¿¿
Lot
Lot Code: D387/UDI(s):L2KSY2-00630414999791; L2KSY6 - 00630414999807
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Related recalls

Questions about this recall

Was Siemens Healthineers Immulite 2000 Systems SYP Syphilis Screen REF(s):L2kSY2/10489085; L2KSY6/10488319 IVD, RxOnly recalled?

Yes. FDA published recall Z-2966-2026 on August 26, 2026. Reported hazard: Syphilis Screen assay may contain a negative patient bias resulting in low reactive patient results being reported as nonreactive.

What should I do if I have this product?

Voluntary: Firm initiated · Letter